OrbusNeich Medical Group Holdings Limited (HKG:6929)

Market Cap	3.48B +10.5%
Revenue (ttm)	1.40B +10.0%
Net Income	326.12M +5.5%
EPS	0.40 +5.6%
Shares Out	823.25M
PE Ratio	10.70
Forward PE	10.01
Dividend	0.12 (2.85%)
Ex-Dividend Date	Jun 10, 2026

Volume	136,000
Open	4.300
Previous Close	4.230
Day's Range	4.100 - 4.300
52-Week Range	3.450 - 5.710
Beta	-0.65
Analysts	Strong Buy
Price Target	5.66 (+34.44%)
Earnings Date	Mar 12, 2026

About HKG:6929

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, drug-coated balloons and stents for lesion therapy, non-compliant balloons for post-dilatation, and specialty catheters, as well as microcatheters, guide catheter extension, dual therapy, and drug eluting stents. Its ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2001
• Employees: 1,477
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6929

Financial Performance

In 2025, HKG:6929's revenue was $180.45 million, an increase of 9.97% compared to the previous year's $164.10 million. Earnings were $41.90 million, an increase of 5.49%.

Financial numbers in USD